An ongoing dialogue on HIV/AIDS, infectious diseases,
March 28th, 2010
Kidneys: Fortunately, We Have Two
Here’s a case over in our Journal Watch: AIDS Clinical Care site: a man with suspected PCP develops rapidly progressive renal failure after being starting on both empiric PCP treatment with TMP-SMX and ART with TDF/FTC plus darunavir/ritonavir.
The specific questions at the end of the case were:
- What do you think is causing the renal failure?
- Would you continue empiric treatment for PCP or try to confirm the diagnosis?
- If you would continue empiric treatment, would you modify it?
- What would you do with his ART? Specifically, would you continue the tenofovir?
- What would be your preferred alternative regimen?
I ran into the nephrologist Jonathan Winston this weekend, who will providing his take on the case shortly. He asked me what actually happened.
Stay tuned …
[Edit: Outcome of case now posted here.]
Categories: Antiretroviral Rounds, Health Care, HIV, Patient Care
Tags: ART, PCP, renal failure, tenofovir
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
-
-
From the Blog — Most Recent Articles
- DOTS: Optimism Around a “Negative” Dalbavancin Trial October 10, 2025
- Update on Louie and One Interesting ID Fact October 3, 2025
- My Dog Louie, the Best Dog Ever, Is Seriously Ill September 26, 2025
- Two Drugs, Not Three: The DOLCE Study in Advanced HIV Disease September 19, 2025
- When Required Learning Modules Surprise You (In a Good Way) September 10, 2025
NEJM Journal Watch — Recent Infectious Disease Articles
- Trends in Carbapenemase-Producing Carbapenem-Resistant Enterobacterales, 2019−2023
- It's Not Always “Just the Flu”
- RSVpreF Vaccine's Effects on Severe Outcomes of RSV Infection
- Should Early Empirical Mold-Active Antifungals Be Given for Severe Influenza Pneumonia?
- Influenza Immunization for Inpatients with Advanced Heart Failure: Is it Beneficial?
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster